Amgen Inc (NASDAQ:AMGN)
| 242.52 BATS BZX Real-Time Price As of 12:34pm ET |  -0.83 / -0.34%Today’s Change | 198.64 Today|||52-Week Range 258.45 | +7.80% Year-to-Date |
Latest AMGN News | Press Releases
| Amgen's Beating the Market -- Here's Why It's a Buy Now 10:00am / MotleyFool.com - Paid Partner Content | 2 Stocks That Could Survive the Next Recession Jun 27 / MotleyFool.com - Paid Partner Content |
| 5 "Strong Buy" Pharmaceutical Stocks to Own for the Long Haul Jun 29 / StockNews.com - Paid Partner Content | Still Think Tesla Is Expensive? This Stat Will Change Your Mind Jun 27 / MotleyFool.com - Paid Partner Content |
| Amgen (AMGN) Stock Moves -0.55%: What You Should Know Jun 28 / Zacks.com - Paid Partner Content | Radius (RDUS) to Go Private With $890M Deal, Shares Gain Jun 24 / Zacks.com - Paid Partner Content |
| Amgen (AMGN) Stock Moves -0.21%: What You Should Know Jun 27 / Zacks.com - Paid Partner Content | Radius (RDUS), Menarini Submit NDA for Breast Cancer Drug Jun 23 / Zacks.com - Paid Partner Content |
| Amgen's Big Bet on Copycat Drugs Is Paying Off Jun 27 / GuruFocus News - Paid Partner Content | Could 2023 Be a Breakout Year for This Pharma Stock? Jun 22 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 243.35 |
| Today’s open | 242.00 |
| Day’s range | 240.75 - 243.96 |
| Volume | 75,628 |
| Average volume (3 months) | 3,295,789 |
| Market cap | $131.1B |
Data as of 12:34pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -16.60% |
| Earnings growth (this year) | +2.14% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +2.94% |
| P/E ratio | 23.9 |
| Price/Sales | 4.96 |
| Price/Book | 20.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -0.16 | -0.26% |
| MRNAModerna Inc | +7.30 | +5.11% |
| BIIBBiogen | +2.52 | +1.24% |
| ILMNIllumina Inc | +3.40 | +1.84% |
Data as of 12:34pm ET, 07/01/2022
Financials
| Next reporting date | August 2, 2022 |
| EPS forecast (this quarter) | $4.40 |
| Annual revenue (last year) | $26.0B |
| Annual profit (last year) | $5.9B |
| Net profit margin | 22.68% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
